Interleukin receptor antagonist-containing product   770620001

SNOMED CT code


SNOMED code770620001
nameInterleukin receptor antagonist-containing product
statusactive
date introduced2019-01-31
fully specified name(s)Product containing interleukin receptor antagonist (product)
synonymsInterleukin receptor antagonist-containing product
attributes - group1
Has active ingredientInterleukin receptor antagonist   716044007
parentsImmunomodulator-containing product   108940007
children
  • Benralizumab-containing product   763652003
  • Brodalumab-containing product   763604008
  • Guselkumab-containing product   763578000
  • Interleukin 1 receptor antagonist-containing product   430817009
  • Interleukin 23 receptor antagonist-containing product   771678003
  • Interleukin 5 receptor antagonist-containing product   770621002
  • Interleukin-4 receptor alpha antagonist-containing product   764413006
  • Ixekizumab-containing product   763603002
  • Recombinant interleukin 1 receptor antagonist-containing product   433451001
  • Sarilumab-containing product   763522001
  • Satralizumab-containing product   897291006
  • Tagraxofusp-containing product   783577002
hierarchies
a selection of possible paths
SNOMED CT Concept   138875005
  Pharmaceutical / biologic product   373873005
    Medicinal product   763158003
      Medicinal product categorized by disposition   766779001
        Immunomodulator-containing product   108940007
          Interleukin receptor antagonist-containing product   770620001

ancestors
sorted most to least specific
cpt crosswalks

Rules-based maps relating CPT® codes to and from SNOMED CT® clinical concepts.  Forward and backward mapping allows for easy transition between code sets. Map-A-Code crosswalk tool easily crosswalks multiple codes between the code sets.

Access to this feature is available in the following products:
  • CPT® to SNOMED Crosswalks

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.